Rep. Byron Donalds discloses trade(s) in ABT, BTC, FIX
Byron Donalds (FL19) disclosed 5 transactions, traded Dec 4 – Dec 18: 3 purchases and 2 sales.
| Traded | Ticker | Company | Action | Amount | Owner |
|---|---|---|---|---|---|
| Dec 18 | BTC | Moran Wealth IRA Bitcoin | Buy | $50,001 - $100,000 | Self |
| Dec 4 | ABT | Abbott Laboratories | Sell | $1,001 - $15,000 | Self |
| Dec 4 | ABT | Abbott Laboratories | Sell | $1,001 - $15,000 | Spouse |
| Dec 4 | FIX | Comfort Systems USA, Inc. | Buy | $1,001 - $15,000 | Self |
| Dec 4 | FIX | Comfort Systems USA, Inc. | Buy | $1,001 - $15,000 | Spouse |
ORIGINAL FILING ↗ALL FILINGS BY BYRON DONALDS →CONGRESS TRADES DASHBOARD →
Amounts are the ranges members report. Rows are read automatically from the filing; a trade split across a page break can be missed, so the original filing is the full record.
What This Means
Congressional stock trading disclosures are routine filings that reveal lawmakers' personal investment activity. Such disclosures can signal confidence or hedging in specific sectors and are tracked by governance-focused investors as a potential indicator of insider sentiment, though individual trades carry limited predictive weight. The disclosure itself is a governance transparency mechanism rather than a market-moving event.
Sources (1)
Every claim below links directly to the original reporting it was drawn from. Penblock synthesizes and cross-references these sources — it doesn't originate the reporting.
- Hon. Byron DonaldsSep 27, 2026View the original filing at the House Clerk ↗
How This Could Play Out
First assessed Sep 27
Resolved
LIKELYNo market impact; this is routine congressional disclosure filing that satisfies STOCK Act transparency requirements and closes the reporting cycle for these transactions.
Status quo
LIKELYThe disclosure remains a minor data point in the public record with no meaningful effect on ABT, BTC, or FIX valuations, as individual congressional trades at this scale rarely move markets or trigger regulatory scrutiny.
Worsens
UNLIKELYIf subsequent investigation or media scrutiny revealed timing conflicts with committee work, non-public information access, or violations of trading restrictions, it could generate reputational pressure on the member and potentially amplify broader congressional trading reform debate, though direct security price impact would remain minimal.
More on Congressional Stock Trading
- Rep. Julie Johnson discloses trade(s) in WBDNov 10
- Rep. Gilbert Cisneros discloses trade(s) in ARE, LNT, APP, ARGX, BNSNov 10
- Rep. Charles J. "Chuck" Fleischmann files a Periodic Transaction ReportNov 10
- Rep. Thomas Suozzi files a Periodic Transaction ReportNov 9
- Rep. David Kustoff discloses trade(s) in WBDNov 9
- Rep. Nancy Pelosi discloses trade(s) in WBDNov 6
Get the market digest by email
One email each morning: yesterday's key story and what it means for markets. Free.